Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published 13 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Sales of seed crystals are expected to remain solid, while full-year sales of substrate- and wafer-related products are expected to fall below the previous fiscal year's actual results. Manufacturing direct costs declined by approximately 33% year on year, while selling expenses increased by approximately 10% due to higher outsourcing costs and other factors. Inventory valuation losses on products, parent crystals, work in process and other items were substantially higher than initially expected, causing the loss to exceed the forecast.
Inventory valuation loss (products, parent crystals and work in process, among other items). Amount: Not disclosed.
| Item | Details |
|---|---|
| Net Sales | ¥1,100 million → ¥1,117 million（+1.5%） |
| Operating profit | ¥-283 million → ¥-413 million |
| Ordinary income | ¥-189 million → ¥-343 million |
| Profit attributable to owners of the parent | ¥-195 million → ¥-348 million |
| Net income per share | ¥-12.60 → ¥-18.29 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 May 2026 |
| Previous-period results | Consolidated: revenue ¥516 million, operating loss ¥1,360 million, ordinary loss ¥1,341 million, net loss attributable to owners of the parent ¥2,415 million, net loss per share ¥164.94. Non-consolidated: revenue ¥550 million, ordinary loss ¥929 million, net loss ¥897 million, net loss per share ¥173.47. |
| Reason for the revision | Sales of seed crystals are expected to remain solid, while full-year sales of substrate- and wafer-related products are expected to fall below the previous fiscal year's actual results. Manufacturing direct costs declined by approximately 33% year on year, while selling expenses increased by approximately 10% due to higher outsourcing costs and other factors. Inventory valuation losses on products, parent crystals, work in process and other items were substantially higher than initially expected, causing the loss to exceed the forecast. |
| Details and amount of extraordinary loss | Inventory valuation loss (products, parent crystals and work in process, among other items). Amount: Not disclosed. |
| Consolidated / non-consolidated | Consolidated / non-consolidated (standalone) |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales of seed crystals are expected to remain solid, while full-year sales of substrate- and wafer-related products are expected to fall below the previous fiscal year's actual results, leaving revenue broadly in line with the original forecast. On the earnings front, manufacturing direct costs declined by approximately 33% year on year and total costs also decreased. However, the loss exceeded the forecast because selling expenses, including outsourcing costs, increased and inventory valuation losses on products, parent crystals, work in process and other items were substantially higher than initially expected.